Skip to main content
Top
Published in: Journal of Gastroenterology 7/2019

01-07-2019 | Metastasis | Original Article—Alimentary Tract

Marked impact of tumor location on the appropriate cutoff values and the prognostic significance of the lymph node ratio in stage III colon cancer: a multi-institutional retrospective analysis

Authors: Eiji Shinto, Hideyuki Ike, Jin-ichi Hida, Hirotoshi Kobayashi, Yojiro Hashiguchi, Yoshiki Kajiwara, Kazuo Hase, Hideki Ueno, Kenichi Sugihara

Published in: Journal of Gastroenterology | Issue 7/2019

Login to get access

Abstract

Background

The prognostic significance of lymph node ratio (LNR) is not constant among studies. Exploration of appropriate location-specific cutoffs might be necessary because the number of lymph nodes harvested is generally higher in right than in left colon cancer. We aimed to determine appropriate cutoff values of LNR in right and left colon cancer and to clarify its clinical significance.

Methods

The clinicopathologic data of 5463 patients with stage III colon cancer were collected. The best cutoff for LNR as a prognostic indicator for patients with right and left colon cancer was studied separately. We compared the prognostic impact between LNR and the number of lymph node metastasis using the Akaike information criterion (AIC), and evaluated the prognostic significance of LNR in each stage III subcategory.

Results

The best performance was noted when LNR was categorized by cutoffs of 0.16 and 0.22 for right and left colon cancer, respectively. AIC scores were better with these categorizations than with subgrouping by number of positive nodes. LNR-low right colon cancer patients showed better cancer-specific survival than LNR-high in stage IIIA (95.7% vs. 89.3%), IIIB (86.7% vs. 77.2%), and IIIC (71.2% vs. 58.7%). The same results were obtained in left colon cancer patients with stage IIIB (88.3% vs. 80.7%) and IIIC (79.8% vs. 68.4%).

Conclusions

We demonstrated the difference in the appropriate cutoffs of LNR between right and left colon cancer. Categorization by location-specific cutoff of LNR may be useful for risk stratification of patients with stage III cancer.
Literature
1.
go back to reference Berger AC, Sigurdson ER, LeVoyer T, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005;23:8706–12.CrossRefPubMed Berger AC, Sigurdson ER, LeVoyer T, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol. 2005;23:8706–12.CrossRefPubMed
2.
go back to reference Rosenberg R, Friederichs J, Schuster T, et al. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period. Ann Surg. 2008;248:968–78.CrossRefPubMed Rosenberg R, Friederichs J, Schuster T, et al. Prognosis of patients with colorectal cancer is associated with lymph node ratio: a single-center analysis of 3,026 patients over a 25-year time period. Ann Surg. 2008;248:968–78.CrossRefPubMed
3.
go back to reference Vaccaro CA, Im V, Rossi GL, et al. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons. Dis Colon Rectum. 2009;52:1244–50.CrossRefPubMed Vaccaro CA, Im V, Rossi GL, et al. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons. Dis Colon Rectum. 2009;52:1244–50.CrossRefPubMed
4.
go back to reference Parnaby CN, Scott NW, Ramsay G, et al. Prognostic value of lymph node ratio and extramural vascular invasion on survival for patients undergoing curative colon cancer resection. Br J Cancer. 2015;113:212–9.CrossRefPubMedPubMedCentral Parnaby CN, Scott NW, Ramsay G, et al. Prognostic value of lymph node ratio and extramural vascular invasion on survival for patients undergoing curative colon cancer resection. Br J Cancer. 2015;113:212–9.CrossRefPubMedPubMedCentral
5.
go back to reference Schumacher P, Dineen S, Barnett C Jr, et al. The metastatic lymph node ratio predicts survival in colon cancer. Am J Surg. 2007;194:827–31.CrossRefPubMed Schumacher P, Dineen S, Barnett C Jr, et al. The metastatic lymph node ratio predicts survival in colon cancer. Am J Surg. 2007;194:827–31.CrossRefPubMed
6.
go back to reference Bilimoria KY, Palis B, Stewart AK, et al. Impact of tumor location on nodal evaluation for colon cancer. Dis Colon Rectum. 2008;51:154–61.CrossRefPubMed Bilimoria KY, Palis B, Stewart AK, et al. Impact of tumor location on nodal evaluation for colon cancer. Dis Colon Rectum. 2008;51:154–61.CrossRefPubMed
7.
go back to reference Ishihara S, Murono K, Sasaki K, et al. Impact of primary tumor location on postoperative recurrence and subsequent prognosis in nonmetastatic colon cancers: a multicenter retrospective study using a propensity score analysis. Ann Surg. 2018;267:917–21.CrossRefPubMed Ishihara S, Murono K, Sasaki K, et al. Impact of primary tumor location on postoperative recurrence and subsequent prognosis in nonmetastatic colon cancers: a multicenter retrospective study using a propensity score analysis. Ann Surg. 2018;267:917–21.CrossRefPubMed
8.
go back to reference Wang SJ, Lemieux A, Kalpathy-Cramer J, et al. Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol. 2011;29:4627–32.CrossRefPubMedPubMedCentral Wang SJ, Lemieux A, Kalpathy-Cramer J, et al. Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol. 2011;29:4627–32.CrossRefPubMedPubMedCentral
9.
go back to reference Ueno H, Mochizuki H, Akagi Y, et al. Optimal colorectal cancer staging criteria in TNM classification. J Clin Oncol. 2012;30:1519–26.CrossRefPubMed Ueno H, Mochizuki H, Akagi Y, et al. Optimal colorectal cancer staging criteria in TNM classification. J Clin Oncol. 2012;30:1519–26.CrossRefPubMed
10.
go back to reference JSCCR: Japanese Classification of Colorectal Carcinoma Second English ed. Tokyo: Kanehara; 2009. JSCCR: Japanese Classification of Colorectal Carcinoma Second English ed. Tokyo: Kanehara; 2009.
11.
go back to reference Watanabe T, Itabashi M, Shimada Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 2015;20:207–39.CrossRefPubMedPubMedCentral Watanabe T, Itabashi M, Shimada Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 2015;20:207–39.CrossRefPubMedPubMedCentral
12.
go back to reference Shinto E, Hida JI, Kobayashi H, et al. Prominent information of jN3 positive in stage III colorectal cancer removed by D3 dissection: retrospective analysis of 6866 patients from a multi-institutional database in Japan. Dis Colon Rectum. 2018;61:447–53.CrossRefPubMed Shinto E, Hida JI, Kobayashi H, et al. Prominent information of jN3 positive in stage III colorectal cancer removed by D3 dissection: retrospective analysis of 6866 patients from a multi-institutional database in Japan. Dis Colon Rectum. 2018;61:447–53.CrossRefPubMed
13.
go back to reference Kobayashi H, Ueno H, Hashiguchi Y, et al. Distribution of lymph node metastasis is a prognostic index in patients with stage III colon cancer. Surgery. 2006;139:516–22.CrossRefPubMed Kobayashi H, Ueno H, Hashiguchi Y, et al. Distribution of lymph node metastasis is a prognostic index in patients with stage III colon cancer. Surgery. 2006;139:516–22.CrossRefPubMed
14.
go back to reference Hida J, Okuno K, Yasutomi M, et al. Number versus distribution in classifying regional lymph node metastases from colon cancer. J Am Coll Surg. 2005;201:217–22.CrossRefPubMed Hida J, Okuno K, Yasutomi M, et al. Number versus distribution in classifying regional lymph node metastases from colon cancer. J Am Coll Surg. 2005;201:217–22.CrossRefPubMed
15.
go back to reference Brierley J, Gospodarowicz M, Wittekind C. TNM classification of malignant tumors. 8th ed. Oxford: Wiley-Blackwell; 2017. Brierley J, Gospodarowicz M, Wittekind C. TNM classification of malignant tumors. 8th ed. Oxford: Wiley-Blackwell; 2017.
16.
go back to reference Akaike H. Information theory and extension of the maximum likelihood principle. In: Kotz S, Johnson NL, editors. Breakthroughs in statistics vol. 1. Foundations and basic theory. New York: Springer-Verlag; 1973. p. 610–24. Akaike H. Information theory and extension of the maximum likelihood principle. In: Kotz S, Johnson NL, editors. Breakthroughs in statistics vol. 1. Foundations and basic theory. New York: Springer-Verlag; 1973. p. 610–24.
17.
go back to reference Meguid RA, Slidell MB, Wolfgang CL, et al. Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol. 2008;15:2388–94.CrossRefPubMedPubMedCentral Meguid RA, Slidell MB, Wolfgang CL, et al. Is there a difference in survival between right- versus left-sided colon cancers? Ann Surg Oncol. 2008;15:2388–94.CrossRefPubMedPubMedCentral
18.
go back to reference Price TJ, Beeke C, Ullah S, et al. Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease? Cancer. 2015;121:830–5.CrossRefPubMed Price TJ, Beeke C, Ullah S, et al. Does the primary site of colorectal cancer impact outcomes for patients with metastatic disease? Cancer. 2015;121:830–5.CrossRefPubMed
19.
go back to reference Yahagi M, Okabayashi K, Hasegawa H, et al. The worse prognosis of right-sided compared with left-sided colon cancers: a systematic review and meta-analysis. J Gastrointest Surg. 2016;20:648–55.CrossRefPubMed Yahagi M, Okabayashi K, Hasegawa H, et al. The worse prognosis of right-sided compared with left-sided colon cancers: a systematic review and meta-analysis. J Gastrointest Surg. 2016;20:648–55.CrossRefPubMed
20.
go back to reference Amri R, Klos CL, Bordeianou L, et al. The prognostic value of lymph node ratio in colon cancer is independent of resection length. Am J Surg. 2016;212:251–7.CrossRefPubMed Amri R, Klos CL, Bordeianou L, et al. The prognostic value of lymph node ratio in colon cancer is independent of resection length. Am J Surg. 2016;212:251–7.CrossRefPubMed
21.
go back to reference Garcia B, Guzman C, Johnson C, et al. Trends in lymph node excision and impact of positive lymph node ratio in patients with colectomy for primary colon adenocarcinoma: population based study 1988 to 2011. Surg Oncol. 2016;25:158–63.CrossRefPubMed Garcia B, Guzman C, Johnson C, et al. Trends in lymph node excision and impact of positive lymph node ratio in patients with colectomy for primary colon adenocarcinoma: population based study 1988 to 2011. Surg Oncol. 2016;25:158–63.CrossRefPubMed
22.
go back to reference Mohan HM, Walsh C, Kennelly R, et al. The lymph node ratio does not provide additional prognostic information compared with the N1/N2 classification in Stage III colon cancer. Colorectal Dis. 2017;19:165–71.CrossRefPubMed Mohan HM, Walsh C, Kennelly R, et al. The lymph node ratio does not provide additional prognostic information compared with the N1/N2 classification in Stage III colon cancer. Colorectal Dis. 2017;19:165–71.CrossRefPubMed
23.
go back to reference Hashiguchi Y, Hase K, Kotake K, et al. Evaluation of the seventh edition of the tumour, node, metastasis (TNM) classification for colon cancer in two nationwide registries of the United States and Japan. Colorectal Dis. 2012;14:1065–74.CrossRefPubMed Hashiguchi Y, Hase K, Kotake K, et al. Evaluation of the seventh edition of the tumour, node, metastasis (TNM) classification for colon cancer in two nationwide registries of the United States and Japan. Colorectal Dis. 2012;14:1065–74.CrossRefPubMed
Metadata
Title
Marked impact of tumor location on the appropriate cutoff values and the prognostic significance of the lymph node ratio in stage III colon cancer: a multi-institutional retrospective analysis
Authors
Eiji Shinto
Hideyuki Ike
Jin-ichi Hida
Hirotoshi Kobayashi
Yojiro Hashiguchi
Yoshiki Kajiwara
Kazuo Hase
Hideki Ueno
Kenichi Sugihara
Publication date
01-07-2019
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 7/2019
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-018-01539-5

Other articles of this Issue 7/2019

Journal of Gastroenterology 7/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.